Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GDTC compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
GDTC
CytoMed Therapeutics Ltd
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
GDTC
CytoMed Therapeutics Ltd
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
GDTC
No earnings history for GDTC.
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
= implied
GDTC realized, solid
LLY realized, hatched
One scale, both sides: full bar = 11%
× = |realized| ÷ implied
Source: market data
GDTC
CytoMed Therapeutics Ltd
Change
0.85
▼
−3.41%
Mkt cap
$10.5M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,358.58
▼
−0.45%
Regular session
Nov 6 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 6 '26
GDTC
CytoMed Therapeutics Ltd
vs
LLY
ELI Lilly & Co
0.85
▼
−3.41%
Price
1,358.58
▼
−0.45%
$10.5M
Mkt cap
$1.2T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
GDTC
0.85
▼
−3.41%
vs
LLY
1,358.58
▼
−0.45%
Regular session
Nov 6 '26